Literature DB >> 3136320

A new means of inducibly inactivating a cellular protein.

J R Carlson1.   

Abstract

This paper presents a general means of eliminating the function of a single protein without relying on genetic alterations in its structure or level of synthesis. The strategy is based on the inducible cellular expression of neutralizing antibody to inactivate the protein selectively. The feasibility of this approach is illustrated by using alcohol dehydrogenase I (ADH I) in Saccharomyces cerevisiae as a model. Heavy- and light-chain cDNAs were isolated from a hybridoma secreting an antibody which neutralizes yeast ADH I. The cDNAs were characterized with respect to their length and identity, their signal sequences were removed, and synthetic translation initiation codons were joined to them. These truncated sequences were then inserted into an inducible expression vector and shown to be expressed as stable heavy and light chains, which assemble and bind antigen. The sequences were introduced into yeast mutants containing different levels of ADH activity, and evidence is provided that the antibodies produce limited neutralization of enzyme activity in vivo. In principle, the approach can be used for any cell type in which functional antibody can be inducibly expressed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136320      PMCID: PMC363466          DOI: 10.1128/mcb.8.6.2638-2646.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

1.  Microinjection of anticlathrin antibodies into fibroblasts does not interfere with the receptor-mediated endocytosis of alpha2-macroglobulin.

Authors:  J Wehland; M C Willingham; R Dickson; I Pastan
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

2.  A mutant immunoglobulin light chain is formed by aberrant DNA- and RNA-splicing events.

Authors:  J G Seidman; P Leder
Journal:  Nature       Date:  1980-08-21       Impact factor: 49.962

3.  A single VH gene segment encodes the immune response to phosphorylcholine: somatic mutation is correlated with the class of the antibody.

Authors:  S Crews; J Griffin; H Huang; K Calame; L Hood
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

4.  Diversity of germ-line immunoglobulin VH genes.

Authors:  D Givol; R Zakut; K Effron; G Rechavi; D Ram; J B Cohen
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

5.  Organization of kappa light chain genes in germ-line and somatic tissue.

Authors:  R Joho; I L Weissman; P Early; J Cole; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

6.  Sequences that regulate the divergent GAL1-GAL10 promoter in Saccharomyces cerevisiae.

Authors:  M Johnston; R W Davis
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

7.  Two kappa immunoglobulin genes are expressed in the myeloma S107.

Authors:  S P Kwan; E E Max; J G Seidman; P Leder; M D Scharff
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

8.  The synthesis and in vivo assembly of functional antibodies in yeast.

Authors:  C R Wood; M A Boss; J H Kenten; J E Calvert; N A Roberts; J S Emtage
Journal:  Nature       Date:  1985 Apr 4-10       Impact factor: 49.962

9.  Transformation of intact yeast cells treated with alkali cations.

Authors:  H Ito; Y Fukuda; K Murata; A Kimura
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

10.  The primary structure of the Saccharomyces cerevisiae gene for alcohol dehydrogenase.

Authors:  J L Bennetzen; B D Hall
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

View more
  25 in total

Review 1.  Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins.

Authors:  David C Butler; Julie A McLear; Anne Messer
Journal:  Prog Neurobiol       Date:  2011-11-18       Impact factor: 11.685

Review 2.  Potential applications of intracellular antibodies (intrabodies) in stem cell therapeutics.

Authors:  Boon Chin Heng; David Michael Kemeny; Hua Liu; Tong Cao
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

Review 3.  Transgenic regulation in laboratory animals.

Authors:  S Rusconi
Journal:  Experientia       Date:  1991-09-15

4.  mRNA display selection of a high-affinity, modification-specific phospho-IkappaBalpha-binding fibronectin.

Authors:  C Anders Olson; Hsiang-I Liao; Ren Sun; Richard W Roberts
Journal:  ACS Chem Biol       Date:  2008-07-01       Impact factor: 5.100

5.  Apoplastic and cytosolic expression of full-size antibodies and antibody fragments in Nicotiana tabacum.

Authors:  S Schillberg; S Zimmermann; A Voss; R Fischer
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

6.  Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization.

Authors:  E Alirahimi; A Ashkiyan; F Kazemi-Lomedasht; K Azadmanesh; M Hosseininejad-Chafi; M Habibi-Anbouhi; R Moazami; M Behdani
Journal:  Cancer Gene Ther       Date:  2016-12-16       Impact factor: 5.987

7.  Secretion of a functional single-chain Fv protein in transgenic tobacco plants and cell suspension cultures.

Authors:  S Firek; J Draper; M R Owen; A Gandecha; B Cockburn; G C Whitelam
Journal:  Plant Mol Biol       Date:  1993-11       Impact factor: 4.076

Review 8.  A new use for intracellular antibody expression: inactivation of human immunodeficiency virus type 1.

Authors:  J R Carlson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

Review 9.  Exposing plasmids as the Achilles' heel of drug-resistant bacteria.

Authors:  Julia J Williams; Paul J Hergenrother
Journal:  Curr Opin Chem Biol       Date:  2008-07-14       Impact factor: 8.822

10.  mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein.

Authors:  Hsiang-I Liao; C Anders Olson; Seungmin Hwang; Hongyu Deng; Elaine Wong; Ralph S Baric; Richard W Roberts; Ren Sun
Journal:  J Biol Chem       Date:  2009-04-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.